Evidence map›Paper›PMID 29674705›Full record

ArticleScientific reports2018

Children with cerebral malaria or severe malarial anaemia lack immunity to distinct variant surface antigen subsets.

Mark A Travassos, Amadou Niangaly, Jason A Bailey, Amed Ouattara, Drissa Coulibaly, Kirsten E Lyke, Matthew B Laurens, Jozelyn Pablo, Algis Jasinskas, Rie Nakajima and 15 more

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Genome-Wide Analysis of the Malaria ParasiteFrontiers in immunology · 2020
    Trial
  2. Review
  3. Article
  4. Conserved multiepitopes inEmerging microbes & infections · 2025
    Article
  5. Article
  6. Diamonds in the rif: Alignment-free comparative genomics analysis reveals strain-transcendent Plasmodium falciparum antigens amidst extensive genetic diversity.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Mark A TravassosDivision of Malaria Research, Institute for Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America. mtravass@som.umaryland.edu.
Amadou NiangalyMalaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Jason A BaileyDivision of Malaria Research, Institute for Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Amed OuattaraDivision of Malaria Research, Institute for Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Drissa CoulibalyMalaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Kirsten E LykeDivision of Malaria Research, Institute for Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Matthew B LaurensDivision of Malaria Research, Institute for Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Jozelyn PabloDivision of Infectious Diseases, Department of Medicine, University of California, Irvine, California, United States of America.
Algis JasinskasDivision of Infectious Diseases, Department of Medicine, University of California, Irvine, California, United States of America.
Rie NakajimaDivision of Infectious Diseases, Department of Medicine, University of California, Irvine, California, United States of America.
Andrea A BerryDivision of Malaria Research, Institute for Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Matthew AdamsDivision of Malaria Research, Institute for Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Christopher G JacobWellcome Trust Sanger Institute, Hinxton, United Kingdom.
Andrew PikeDivision of Malaria Research, Institute for Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Shannon Takala-HarrisonDivision of Malaria Research, Institute for Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Li LiangDivision of Infectious Diseases, Department of Medicine, University of California, Irvine, California, United States of America.
Bourema KouribaMalaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Abdoulaye K KoneMalaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
J Alexandra RoweCentre for Immunity, Infection and Evolution, Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0002-7702-1892
JoAnn MouldsLifeShare Blood Centers, Shreveport, Louisiana, United States of America.
Dapa A DialloMalaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Ogobara K DoumboMalaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Mahamadou A TheraMalaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Philip L FelgnerDivision of Infectious Diseases, Department of Medicine, University of California, Irvine, California, United States of America.
Christopher V PloweDuke Global Health Institute, Duke University, Durham, North Carolina, United States of America.

Funding

Safety, Immunogenicity and Efficacy of VaccineU19AI065683 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BLACKWELDER, WILLIAM C. · 2005 to 2009
$4.7M
MALARIA RESEARCH TRAINING IN MALID43TW001589 · FIC · UNIVERSITY OF MARYLAND BALTIMORE · PI PLOWE, CHRISTOPHER V. · 2000 to 2015
$2.8M
Malaria:Clinical Research and Trial Preparation Sites-26685346N01AI085346 · NIAID · Univ Maryland · 1998 to 2004
$2.8M
Immuno-epidemiological epitope mapping of a blood stage malaria vaccine antigenR01AI093635 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI PLOWE, CHRISTOPHER V. · 2012 to 2015
$2.3M
Variant surface antigens in cerebral malaria pathogenesisR01HL130750 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI FISHER, STEVEN A., HARRISON, SHANNON TAKALA · 2015 to 2018
$2.1M
Protein microarray antibody responses to P. falciparum in a human challenge modelK23AI125720 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BERRY, ANDREA · 2017 to 2021
$915k
Host vulnerability and parasite genetics in the development of cerebral malariaR01AI099628 · NIAID · UNIV OF SCIENCES, TECH & TECH OF BAMAKO · PI THERA, MAHAMADOU ALI · 2014 to 2018
$625k
FIC NIH HHS D43 TW001589Howard Hughes Medical InstituteNHLBI NIH HHS R01 HL130750NIAID NIH HHS K23 AI125720NIAID NIH HHS N01 AI085346NIAID NIH HHS R01 AI093635NIAID NIH HHS R01 AI099628NIAID NIH HHS U19 AI065683
6 · The paper itself

Abstract

Variant surface antigens (VSAs) play a critical role in severe malaria pathogenesis. Defining gaps, or "lacunae", in immunity to these Plasmodium falciparum antigens in children with severe malaria would improve our understanding of vulnerability to severe malaria and how protective immunity develops. Using a protein microarray with 179 antigen variants from three VSA families as well as more than 300 variants of three other blood stage P. falciparum antigens, reactivity was measured in sera from Malian children with cerebral malaria or severe malarial anaemia and age-matched controls. Sera from children with severe malaria recognized fewer extracellular PfEMP1 fragments and were less reactive to specific fragments compared to controls. Following recovery from severe malaria, convalescent sera had increased reactivity to certain non-CD36 binding PfEMP1s, but not other malaria antigens. Sera from children with severe malarial anaemia reacted to fewer VSAs than did sera from children with cerebral malaria, and both of these groups had lacunae in their seroreactivity profiles in common with children who had both cerebral malaria and severe malarial anaemia. This microarray-based approach may identify a subset of VSAs that could inform the development of a vaccine to prevent severe disease or a diagnostic test to predict at-risk children.

Indexed as

AnemiaAntigens, ProtozoanCase-Control StudiesChild, PreschoolFemaleHumansInfantMalaria, CerebralMalaria, FalciparumMalePlasmodium falciparumAntigens, Protozoan

Identifiers

PMID29674705
PMCPMC5908851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.